Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 581, Issue 1-2, 2005, Pages 97-104

  Gu, Jian ^a   Liang, Dong ^b   Wang, Yunfei ^a   Lu, Charles ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Bladder cancer; N Acetyl transferase gene; Polymorphism; Tobacco smoke

Indexed keywords

ACETYLATOR PHENOTYPE; ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER GENETICS; CARCINOGENESIS; CAUCASIAN; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; ETHNOLOGY; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENOTYPE; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; N ACETYLTRANSFERASE 1 GENE; N ACETYLTRANSFERASE 2 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

NICOTIANA TABACUM;

EID: 13844266270     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.11.012     Document Type: Article

References (24)

1. H. Anton-Culver, A. Lee-Feldstein, and T.H. Taylor The association of bladder cancer risk with ethnicity, gender, and smoking Ann. Epidemiol. 3 4 1993 429 433
2. S.S. Hecht Tobacco smoke carcinogens and lung cancer J. Natl. Cancer Inst. 91 14 1999 1194 1210
3. D.W. Hein, M.A. Doll, T.D. Rustan, K. Gray, Y. Feng, R.J. Ferguson, and D.M. Grant Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases Carcinogenesis 14 1993 1633 1638
4. D.W. Hein, M.A. Doll, A.J. Fretland, M.A. Leff, S.J. Webb, G.H. Xiao, U.S. Devanaboyina, N.A. Nangju, and Y. Feng Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol. Biomarkers Prev. 9 2000 29 42
5. A.F. Badawi, A. Hirvonen, D.A. Bell, N.P. Lang, and F.F. Kadlubar Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder Cancer Res. 55 1995 5230 5237
6. M. Blum, D.M. Grant, W. McBride, M. Heim, and U.A. Meyer Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression DNA Cell. Biol. 9 1990 193 203
7. D.A. Bell, A.F. Badawi, N.P. Lang, K.F. Ilett, F.F. Kadlubar, and A. Hirvonen Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1 * 10 allele with higher N-acetylation activity in bladder and colon tissue Cancer Res. 55 1995 5226 5229
8. N.C. Hughes, S.A. Janezic, K.L. McQueen, M.A. Jewett, T. Castranio, D.A. Bell, and M. Grant Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe Pharmacogenetics 8 1998 55 66
9. M.A. Doll, W. Jiang, A.C. Deitz, T.D. Rustan, and D.W. Hein Identification of a novel allele at the human NAT1 acetyltransferase locus Biochem. Biophys. Res. Commun. 233 1997 584 591
10. J.A. Taylor, D.M. Umbach, E. Stephens, T. Castranio, D. Paulson, C. Robertson, J.L. Mohler, and D.A. Bell The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction Cancer Res. 58 1998 3603 3610
11. T. Katoh, H. Inatomi, M. Yang, T. Kawamoto, T. Matsumoto, and D.A. Bell Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese Pharmacogenetics 9 3 1999 401 404
12. H. Okkels, T. Sigsgaard, H. Wolf, and H. Autrup Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking Cancer Epidemiol. Biomarkers Prev. 6 1997 225 231
13. R.J. Hung, P. Boffetta, P. Brennan, C. Malaveille, A. Hautefeuille, F. Donato, U. Gelatti, M. Spaliviero, D. Placidi, A. Carta, A. Scotto di Carlo, and S. Porru GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population Int. J. Cancer 110 4 2004 598 604
14. I. Cascorbi, I. Roots, and J. Brockmoller Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1 * 10 Cancer Res. 61 2001 5051 5056
15. D.A. Bell, J.A. Taylor, M.A. Butler, E.A. Stephens, J. Wiest, L.H. Brubaker, F.F. Kadlubar, and G.W. Lucier Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans Carcinogenesis 14 1993 1689 1692
16. D. Hickman, A. Risch, J. Camilleri, and E. Sim Genotyping human polymorphic arylamine N-acetyltransferase: identification of slow allotypic variants Phamacogenetics 2 1992 217 226
17. P.M. Marcus, P. Vineis, and N. Rothman NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population Pharmacogenetics 10 2000 115 122
18. Green, E. Banks, A. Berrington, S. Darby, H. Deo, R. Newton, N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction, Br. J. Cancer 83 (2000) 412-417
19. Vineis, D. Marinelli, H. Autrup, J. Brockmoller, I. Cascorbi, A.K. Daly, Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies, Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1249-1252.
20. L.E. Johns, and R.S. Houlston N-acetyl transferase-2 and bladder cancer risk: a meta-analysis Environ. Mol. Mutagen. 36 2000 221 227
21. D.A. Bell, E.A. Stephens, T. Castranio, D.M. Umbach, M. Watson, M. Deakin, J. Elder, C. Hendrickse, H. Duncan, and R.C. Strange Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer Cancer Res. 55 1995 3537 3542
22. J.A. Agundez, M. Olivera, C. Martinez, J.M. Ladero, and J. Benitez Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population Pharmacogenetics 6 1996 423 428
23. P. Vineis, H. Bartsch, N. Caporaso, A.M. Harrington, F.F. Kadlubar, M.T. Landi, C. Malaveille, P.G. Shields, P. Skipper, and G. Talaska Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens Nature 369 1994 154 156
24. M.C. Yu, P.L. Skipper, K. Taghizadeh, S.R. Tannenbaum, K.K. Chan, and B.E. Henderson Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California J. Natl. Cancer Inst. 86 1994 712 716